Van ECK Associates Corp Boosts Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Van ECK Associates Corp lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 107.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,841,652 shares of the company’s stock after buying an additional 2,506,417 shares during the period. Van ECK Associates Corp owned approximately 1.06% of GE HealthCare Technologies worth $378,520,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. LGT Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 251 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth about $26,000. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Darwin Wealth Management LLC bought a new position in shares of GE HealthCare Technologies during the third quarter worth about $31,000. Finally, Continuum Advisory LLC grew its stake in GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.3 %

Shares of NASDAQ:GEHC opened at $85.90 on Thursday. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The company has a market cap of $39.25 billion, a PE ratio of 23.60, a P/E/G ratio of 2.93 and a beta of 1.15. The company’s 50-day moving average price is $83.58 and its 200 day moving average price is $85.39.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $96.77.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.